What follows is the practical version of that answer, what each vitamin does, how the two tests differ, what a low or high value can reflect, and which markers are worth running in the same blood draw.
Vitamin B6 is a family of related compounds that the body converts into pyridoxal 5'-phosphate, the active cofactor a long list of enzymes depend on. Those enzymes handle amino acid processing, the building of several neurotransmitters, the release of stored glucose, and one branch of the pathway that clears homocysteine. Because B6 works as a cofactor rather than as a structural nutrient, its status shows up in how well those reactions run rather than in one obvious tissue.
The blood test usually reports plasma pyridoxal 5'-phosphate, often shortened to PLP. The Vitamin B6 biomarker page is the place for how that test is run, what the typical and optimal ranges are, and how to read a single result. This guide stays on the comparison, what separates B6 from B12 and when each one is worth measuring.
Vitamin B12 powers two enzyme reactions that no other nutrient can cover. Cobalamin, the chemical name for B12, is the required cofactor for methionine synthase, which recycles homocysteine back into methionine, and for methylmalonyl-CoA mutase, which clears methylmalonyl-CoA on the route to energy production from certain fats and amino acids. When either reaction stalls, the consequences land in two tissues that tolerate interruption poorly, the bone marrow and the nervous system.
In marrow, a block at methionine synthase slows DNA synthesis in developing red blood cells, which is why unusually large red cells are a classic signal. In nerves the picture is broader than a simple energy shortfall, and research suggests that B12 deficiency disturbs myelin maintenance and cell signalling in ways that go beyond the textbook metabolic block 1. Neurological changes can appear before, or without, obvious changes in the blood count, which is why a normal count does not close the question 2.
B12 also differs in how it reaches the bloodstream. It occurs in animal foods and in fortified foods, and absorption depends on stomach acid, on intrinsic factor made by the stomach lining, and on intact receptors in the lower small intestine 2. B6 has no comparable multi-step dependency. That single difference explains most of why the two vitamins fail for different reasons and in different people.
They get confused because they travel together on labels, not because they behave alike. Both are water-soluble B vitamins, both appear in the same combination products, both get marketed around the vague idea of energy, and both are involved in nerve function and in homocysteine handling. From the outside they look interchangeable.
The chemistry says otherwise. B6 is a small pyridine-based molecule the body absorbs readily across the upper small intestine. B12 is a large cobalt-containing structure that needs a carrier protein and a specific receptor to get in. B6 is widespread in both plant and animal foods, while B12 is found in animal foods and fortified foods only. The liver holds a substantial reserve of B12, so a new absorption problem can take a long time to surface, whereas circulating B6 reflects more recent intake and current metabolic demand.
The failure modes diverge too. Low B12 is the far more familiar clinical problem, and it shows up in blood cells and nerves. B6 is unusual among vitamins because attention falls at both ends of its range, low status on one side and excessive long-term intake on the other. Treating the two as one nutrient hides all of that, which is exactly why they are measured separately.
They overlap in one-carbon metabolism, the set of reactions that move methyl groups around and keep homocysteine in check. B12, working with folate, converts homocysteine back into methionine. B6 supports the alternative exit route, the transsulfuration pathway that converts homocysteine onward toward cysteine. Two different doors out of the same room.
That shared territory has a practical consequence for reading labs. A raised homocysteine tells you that one of these pathways is under strain, but it does not name the nutrient responsible, because B12, folate and B6 status all feed into the same number 3. Kidney function and other factors shift it as well, so homocysteine is best read as a functional signal rather than as a stand-in for any single vitamin 4.
Methylmalonic acid behaves differently. It accumulates specifically when the B12-dependent mutase reaction slows, which makes it the more selective functional marker for B12 and gives it no useful role in assessing B6 3. So the overlap is real at the level of biochemistry, but the laboratory can still separate the two if the right markers are ordered together.
They appear as separate lines with different units, which is the first clue that they are not interchangeable. B6 is usually reported in ng/mL and B12 in pg/mL, and the functional markers that help interpret B12 come in their own units again.
| Marker | What the blood test measures | Typical lab reference range | FitScript optimal range |
|---|---|---|---|
| Vitamin B6 (plasma PLP) | The active circulating form of vitamin B6 | 5 to 50 ng/mL | 10 to 30 ng/mL |
| Vitamin B12 (serum total B12) | All circulating B12, carried on two different binding proteins | Commonly around 200 to 900 pg/mL, with wide variation between laboratories | Not published here |
| Methylmalonic acid (MMA) | A compound that builds up when B12 is functionally short | Assay specific, read the range printed on your report | Not published here |
| Homocysteine | An amino acid that rises when the B12, folate or B6 routes run short | Assay specific, read the range printed on your report | Not published here |
| Holotranscobalamin (holoTC) | The fraction of B12 that cells can actually take up | Assay specific, read the range printed on your report | Not published here |
These are typical laboratory reference ranges, and they vary by lab, by assay, by age and by sex, so the range printed next to your own result is the one that applies. FitScript's optimal range is an optimization target rather than a diagnostic cut-off, and a value inside or outside it is a starting point for a conversation, not a conclusion.
A low PLP result means the active form of B6 in circulation is running thin, and several unrelated situations can produce that. Low intake over time is one. Poor absorption is another. Heavy alcohol intake lowers it. Inflammation pulls plasma PLP down independently of intake, which is why an inflammatory marker in the same panel changes how the number should be read. Some medicines affect B6 status, and your prescriber is the person to ask about anything you are taking. Pregnancy and periods of high metabolic demand shift it as well.
What a low value may mean depends on who it belongs to. Research suggests that low vitamin B6 status is associated with sarcopenia, frailty and higher mortality in older adults 5. Research also suggests that vitamin B6 deficiency is associated with peripheral neuropathy, the pattern of numbness, tingling or burning that tends to start in the feet and hands 6.
The useful next step is not to act on the number alone. A single low PLP in the context of an acute illness is a different conversation from a persistently low value in someone with nerve symptoms. Bring the result, the context and any symptoms to a clinician, who can decide whether it needs repeating, interpreting alongside other markers, or acting on.
A low B12 result most often reflects either too little coming in or too little being absorbed, and the second cause is the more common one in adults. Intake runs low in people eating little or no animal food without fortified alternatives. Absorption falters when stomach acid declines with age, when the stomach lining is attacked by an autoimmune process, after surgery on the stomach or lower small intestine, and in conditions affecting the gut wall 2. Some medicines influence B12 absorption, and that is a question for your prescriber rather than for a web page.
The consequences are what make the marker worth watching. B12 deficiency is associated with a range of neurological and haematological changes, and research suggests the nervous system effects involve disruption of myelin and of cellular signalling rather than a simple shortage of fuel 1. In older adults, B12 deficiency is associated with geriatric syndromes including cognitive and functional decline 7.
There is also a grey zone. Total B12 values in the lower part of the standard range are hard to interpret on their own, which is where methylmalonic acid or holotranscobalamin earn their place 4. A borderline B12 with a raised MMA reads very differently from a borderline B12 with a normal one. Either way, a low or borderline result is worth discussing with a clinician rather than filing away.
Yes for B6, and the picture for B12 is different in kind. This is the sharpest practical difference between the two vitamins. Vitamin B6 is one of the few water-soluble vitamins where sustained intake far above what food provides becomes a problem in its own right, and research suggests that excessive vitamin B6 is associated with peripheral neuropathy, typically a sensory pattern in the feet and hands 6. Studies suggest that these sensory symptoms often improve once the excess intake stops, although recovery is not uniform 6.
The awkward part is that low and excessive B6 can produce overlapping symptoms, so the symptom alone does not tell you which end of the range you are on. The blood test does. That is a strong argument for measuring rather than assuming, particularly in anyone taking combination products that contain B6 without noticing.
A high serum B12 result works differently. Because B12 is not stored in circulation in the same way, a high reading most commonly reflects recent supplementation or fortified intake. When a high value appears in someone taking nothing, it can reflect other processes in the liver, kidneys or blood, and it is worth discussing with a clinician promptly rather than dismissing as harmless overflow. Any decision about what to do next, in either direction, belongs to a licensed provider who can see the whole picture.
No symptom list separates them reliably, which is precisely why both are measured. That said, some patterns shift the odds. Unexplained anaemia with unusually large red cells, a sore smooth tongue, pins and needles with loss of position sense, unsteady walking, and changes in memory or mood sit more squarely in the B12 column 2.
B6 rarely announces itself as a single dramatic syndrome in adults. Low status more often turns up as part of a broader picture, and research suggests that low vitamin B6 status is associated with reduced muscle mass and frailty in older adults 5. Nerve symptoms can appear at either end of the B6 range 6.
The honest conclusion is that symptoms raise the question and laboratory markers answer it. New or progressive numbness, tingling, balance problems or cognitive change deserve clinical attention regardless of which vitamin eventually turns out to be relevant, and they deserve it sooner rather than later.
B6 is measured directly and B12 is measured indirectly, and that is the core difference. Plasma pyridoxal 5'-phosphate is the accepted way to look at circulating B6 status, and it is a reasonably direct readout of the active form. The sample is light-sensitive and handling matters, which is one reason results can vary between laboratories.
Serum total B12 is a less tidy measurement. It captures all circulating B12, including the portion bound to a carrier protein that cells cannot easily use, so the total can look adequate while the usable fraction is not 4. This is why interpretation often leans on additional markers. Holotranscobalamin reports the fraction available to cells, while methylmalonic acid and homocysteine report whether the B12-dependent reactions are actually keeping up, and combining indicators gives a more dependable read than any one of them alone 3.
Preparation differs less than people expect. Fasting is usually not required for either, but supplements taken shortly before a draw can lift a reading and obscure the baseline, so the ordering clinician should know what you take and when. FitScript's membership runs 150+ biomarkers tested per year and Atlas, FitScript's AI health advisor, reads each result in the context of the rest of the panel rather than line by line.
The companions that make these two numbers interpretable are folate, methylmalonic acid, homocysteine, a full blood count and a measure of kidney function. Folate belongs in the same conversation because folate and B12 share the remethylation step, and a folate result changes how a raised homocysteine should be read 3.
A full blood count with red cell indices adds the haematological view. Enlarged red cells alongside a low or borderline B12 strengthen the case, while normal indices do not dismiss it, since neurological changes can run ahead of the blood picture. Iron markers matter too, because concurrent iron deficiency can mask the enlarged-cell pattern and leave the count looking unremarkable.
Kidney function belongs on the list for a technical reason. Both methylmalonic acid and homocysteine rise when kidney clearance falls, so a raised functional marker in someone with reduced kidney function does not carry the same meaning as the same value in someone with normal clearance 4. An inflammatory marker is worth having as well, since inflammation lowers plasma PLP and can make B6 look worse than intake would suggest. Read together, these markers turn two isolated vitamin values into something a clinician can actually reason about.
Plenty, which is why a single result is a snapshot rather than a verdict. For B6, inflammation lowers plasma PLP independently of what you eat, so a result drawn during or shortly after an illness can understate true status. Alcohol intake, pregnancy and high metabolic demand all shift it. Assay and handling differences add their own variation between laboratories.
For B12, the largest single confounder is recent supplementation or fortified food, which can lift a serum value without changing what is reaching cells. Binding protein biology matters too, since the proportion of B12 carried on the usable carrier varies between people and the total measurement cannot see that split 4. Pregnancy lowers serum B12 through normal physiological changes, and reduced kidney clearance raises the functional markers used to interpret it 3.
Some medicines affect both vitamins, and the right move there is to ask your prescriber about anything on your list rather than to guess from a symptom or a search result. Timing is the one variable you control directly. Drawing blood under consistent conditions, and telling the laboratory what you have taken recently, makes the comparison between this year's result and last year's mean something.
The two risk profiles only partly overlap. For B12, the groups that come up repeatedly are older adults, people eating little or no animal food without fortified alternatives, people who have had surgery on the stomach or lower small intestine, and people with conditions affecting absorption in the gut 2. Research suggests that B12 deficiency is particularly relevant in older adults, where it is associated with geriatric syndromes such as falls, functional decline and cognitive change 7. Pregnancy and breastfeeding raise demand, and infants of mothers with low status are affected too.
For B6, the picture is less about absorption and more about demand, inflammation and intake. Research suggests that low vitamin B6 status is associated with sarcopenia and frailty in older adults, making age a shared risk factor across both vitamins 5. Heavy alcohol intake, chronic inflammatory conditions and reduced kidney function are also associated with lower circulating PLP.
There is a separate group worth naming for B6, the people whose risk runs in the other direction. Anyone taking several combination products at once can accumulate more B6 than they realise, since it appears in many formulations without being the headline ingredient. For that group, measurement is more informative than estimation.
In most adults, B12 is the higher-yield single test. If one line on a requisition form has to carry the question, that is usually the one.
But that is a triage answer, not a principle. B6 earns its own line in specific situations, including persistent nerve symptoms where excess intake is plausible, older adults being assessed for reduced muscle mass and frailty, and anyone with chronic inflammation where status is harder to predict from diet.
The practical answer is that the two tests answer different questions and testing both plus folate costs little extra once blood is already drawn. What makes the panel useful is interpreting it together. A low-normal B12 with a raised methylmalonic acid, a normal B6 with high inflammation, a raised homocysteine with low folate, each combination points somewhere different, and none of them is readable from one number in isolation.
Any result outside the standard range is worth raising, and some situations are worth raising promptly. New or progressing numbness, tingling, burning in the hands or feet, unsteadiness, memory or mood changes, or unexplained anaemia all deserve prompt clinical attention. A borderline B12 in someone with those symptoms is a reason to look further, not a reason to relax 2.
For B6, a result below the standard range alongside nerve symptoms is worth discussing, and so is a result above it in anyone taking combination products. A suboptimal value with no symptoms is still useful information, just less urgent, and it is usually read alongside inflammation and the rest of the panel rather than on its own.
This page is educational and is not medical advice. Discuss your own results, and any treatment question they raise, with a clinician or licensed provider, since treatment decisions belong to a licensed provider who can review your history, your symptoms and your full panel rather than a single line on a report.
For a related question that comes up often once B12 appears on a panel, see will vitamin b12 increase blood pressure, which looks at what the marker does and does not explain about blood pressure readings.
No. They are chemically different nutrients that support different reactions, come from different food sources and are absorbed in different ways. They also appear as separate lines on a blood panel, reported in different units, so one result tells you nothing about the other.
Not a single combined test, no. B6 is usually measured as plasma pyridoxal 5'-phosphate, while B12 is measured as serum total B12 and often interpreted with extra markers such as methylmalonic acid or holotranscobalamin. If you want to know about both, both need to be ordered.
Fasting is usually not required for either, but follow whatever instructions your laboratory gives for your specific panel. Supplements taken shortly before the draw can lift a reading and make it harder to interpret, so tell the ordering clinician what you take and when you last took it.
A total B12 result inside the standard range does not always settle the question, because the test includes a fraction that cells cannot readily use. A clinician may add a functional marker such as methylmalonic acid, or look at folate, red cell indices and kidney function alongside it. Bring your symptoms and the full panel to that conversation rather than the one value.
Yes, and that is one of the main differences between the two vitamins. B6 appears in many combination products, so levels can climb without a person noticing. A result above the standard range is worth discussing with a clinician, who decides what, if anything, should change.
B12, by a wide margin. It occurs in animal foods and fortified foods, so intake can fall short without fortified alternatives. B6 is found across both plant and animal foods, so diet pattern alone is a weaker predictor of B6 status.
The interval is a clinical decision rather than a fixed rule, and it depends on the first result, your symptoms and whether anything has changed since. A borderline or out-of-range value is usually rechecked sooner than a comfortably mid-range one. Ask the clinician who ordered the test when they want to see it again.
Take it to a clinician with the rest of your panel and any symptoms you have noticed, rather than acting on it alone. Do not ignore an out-of-range value, and raise it promptly if you have new numbness, tingling, balance problems or memory changes. Any next step belongs to a licensed provider who can review your full picture.